The creator is buying Novo Nordisk (NVO) at $48 due to its leading position in the weight loss market and the upcoming release of an oral pill version, seeing it as a high risk/reward play.
Source Post
Follow to stay updated on this play! I’m up $300 already. #nvo #invest #finance #stocks
Nov 13, 2025
The creator discusses Novo Nordisk (NVO), highlighting its strong position in the weight loss drug market with Ozempic and the upcoming oral pill version. Despite a recent stock price drop, the creator sees a significant risk/reward opportunity, having bought shares at $48.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
NVObuy opened Nov 13, 2025
+2.36%